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amount of 340 000 € could have been saved. CONCLUSIONS: Adherence to princi-
ples of good antibiotic policies leads to fundamental short and long term financial
savings within the budget of a health insurance fund.
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OBJECTIVES: Clostridium difficile infection (CDI) can lead to several complications
from mild diarrhoea to toxic megacolon. The objectives of this study were to: 1)
evaluate standard Time trade-off (TTO) and chain TTO techniques for eliciting
utility of CDI-related chronic and temporary health states; 2) compare those values
with those from Healthcare Professional (HCP) EQ-5D valuation; 3) evaluate meth-
ods of calculating utilities for health states worse than death (WTD). METHODS:
Ten health state vignettes were developed from literature with input from HCPs.
Participants from the UK public were interviewed: 50 for the pilot and 100 for the
main study. Each participant provided sociodemographic information, ranking of
health states by preference and responses to a Computer-Assisted Personal Inter-
view TTO protocol for all states considered. HCPs provided EQ-5D data. Methods to
apprehend the impact of extreme negative utilities were appraised: truncation and
monotonic transformation.RESULTS:Temporary health state utilities ranged from
(mean and (/) median from non transformed method; mean and median (/) from
monotonically transformed method): -2.70/0.7;0.39/0.6 for mild diarrhoea to
-32.50/-1.1; -0.23/-0.5 for colectomy. Chronic health state ranged from: -2.37/0.5;
0.35/0.5 for chronic diarrhoea to -7.98/0;-0.13/0 for chronic renal failure. Population
valuations were more severe for most health states when compared with HCP
values. CONCLUSIONS: While transformation has an important impact on results,
nowadays there is no reliable measure of utilities for CDI-health states. The pro-
portion of participants judging health states as WTD was unexpectedly high; ques-
tioning the suitability of face-to-face TTO interview in this disease area. The mono-
tonic transformation was convenient but lacks theoretical grounding. Other
methods like Lead Time trade-off could add value to similar research.
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OBJECTIVES: To investigate health related quality of life (HRQOL) in non-engaging
HIV infected intravenous drug users (IVDUs) over a one year time period.
METHODS: This was a prospective observational cohort study of non-engaging
adult HIV infected IVDUs registered for care at an inner city HIV unit (non-engage-
ment defined as missing  2 HIV outpatient appointments over one year or not
attending outpatients for six months). EQ-5D, SF-36, Hospital Anxiety Depression
scale (HADs), clinical and substance misuse data were collected on a six monthly
basis. Regression models were fitted to identify the statistical relationship between
utility and HADs. The relationship between measures was assessed using spear-
man’s correlation for non-parametric data. RESULTS: Fifty-two patients were in-
cluded (125 observations). Sixty two percent were male with a mean age of 37 yrs.
The mean anxiety value was 10.9 (borderline anxiety), and mean Depression score
was 9.3 (borderline depressed). The mean EQ5D utility score was 0.51(95% CI: 0.45 –
0.59) Fifteen patients (12%) had an EQ5D utility worse than death of whom 14 (93%)
were anxious and 13 (86%) were depressed. The mean SF6D utility was 0.53 (95%CI:
0.51 – 0.55). Mean Physical component score (PCS) was 53.91, and mental compo-
nent score (MCS) was 34.03. Role physical had the lowest mean score at 28.07, and
was significantly correlated with anxiety (spearman’s correlation -0.318, signifi-
cant at 0.01 level, 2 tailed), depression (spearmans’s correlation -0.316, significant
at 0.01 level, 2 tailed), virological suppression (spearman’s correlation -0.194 sig-
nificant at 0.05 level, 2 tailed) and HIV viral load (spearman’s correlation -0.207,
significant at 0.05 level, 2 tailed). CONCLUSIONS: HRQOL was severely reduced in
this non-engaging HIV infected IVDU population. Whilst HCV co-infection and
substance misuse did not affect the HRQOL, anxiety and depression had a signifi-
cant impact upon it.
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OBJECTIVES: Cytomegalovirus (CMV) is responsible directly or indirectly for an
increase of mortality and morbidity in patients with solid organ transplantation
(SOT) and hematopoietic stem cell transplantation (HSCT). Our aim was to identify
HRQoL dimensions affected by CMV infections and management after HSCT or
SOT. METHODS: A literature review on transplanted patients’ HRQoL through the
EMBASE database was performed. We also looked for issues raised by patients in
specialized forums. Individual interviews were conducted with 4 clinical experts
and 20 patients, divided equally into HSCT and SOT groups. Clinical practitioners
were asked to identify key concepts attributable to the CMV-disease (symptoms) or
antiviral side effects versus transplantation-related. Patients were asked to cite
important concepts and rate them. All patient responses were coded. Code fre-
quency and bother ratings were used to identify salient patient experiences.
RESULTS: Preliminary analysis suggests that it is difficult to isolate the effects of
the CMV infection and the antiviral treatment due to other untolerated medica-
tions (e.g. immunosuppressive drugs) and/or the patient’s underlying medical con-
dition. Key reported symptoms include fever and (worsened) tiredness. Tiredness
was often described as being related to physical activity limitation. Key areas im-
pacted by CMV infection and CMV treatment included physical activity and mobil-
ity limitations, as well as mental fatigue and stress. Practitioner judgments helped
classify the different concepts into one of 3 categories, CMV-disease symptom,
treatment side effects, and psychological concerns. CONCLUSIONS: The CMV im-
pact was found to be quite heterogeneous between patients as it seems to be
dependent on type of transplantation, experience of symptomatic infection and
tolerance of antidepressants. This qualitative study suggested that physical activ-
ity, mobility, mental fatigue, and stress are key QoL dimensions affected by CMV
management, infections and treatments in transplanted patients.
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Primary immunodeficiency (PI) constitutes a group of disorders involving a primary
defect in the immune system often requiring lifelong Immunoglobulin (IG) therapy
which can be administered intravenously (IGIV) or subcutaneously (IGSC).
OBJECTIVES: To quantify patient and caregivers preferences for administration
attributes of IG treatments. METHODS: Adult patients and caregivers of children
with PI from 21 non-U.S. countries recruited via national member organisations
completed a web-enabled, choice-format survey. The conjoint analysis quantified
the preferences of attributes presented to the respondents. The preference weights
for each sample were scaled between 0 and 10. The vertical distance between
adjacent preference weights indicated the relative importance of moving from one
level of an attribute to an adjacent level of that attribute. RESULTS: A total of 216
patients and 84 caregivers completed the survey. Patients and caregivers signifi-
cantly preferred monthly to weekly, home setting to doctor’s office/hospital/ clinic,
shorter duration, and fewer needle sticks of IG treatment (P  0.05). There was a
difference in the ranking of these attributes between IGIV and IGSC users. IGIV
users indicated frequency as the most important attribute followed by number of
needle sticks, duration and home setting while IGSC users indicated home setting
as the most important attribute followed by duration, self administration, number
of needle sticks, and frequency. CONCLUSIONS: IG treatments that provide the
comprehensive option of a monthly frequency, home setting, shorter duration, and
fewer needle sticks may address the needs of both PI patients and caregivers,
although ranking of these attributes may be different between the IGIV and IGSC
users.
INFECTION - Health Care Use & Policy Studies
PIN79
HEPATITIS C VIRUS INFECTION INCREASES THE RISK OF ALZHEIMER’S
DISEASES
Chiu WC1, Chen PC2
1Cathay General Hospital, Taipei, Taiwan, 2College of Public Health, National Taiwan University,
Taipei, Taiwan
OBJECTIVES: Hepatitis C virus (HCV) infection may cause cognitive impairment,
but no studies have focused specifically on cognitive impairment stemming from
Alzheimer’s disease. The purpose of this study was to investigate the potential
increased risk for Alzheimer’s disease in HCV-infected patients. METHODS: We
conducted a population-based cohort study from the Taiwan National Health In-
surance Research Database. From all potential participants aged fifty years or
more, a total of 117,098 matched (1:1) pairs of HCV-infected patients and non-HCV-
infected patients were included. Each subject was individually tracked from 1997 to
2009 to identify incident cases of Alzheimer’s disease (onset in 1999 or later). Cox
proportional hazard regressions were employed to calculate the hazard ratios (HRs)
and 95% confidence intervals (CIs) for the association between HCV infection and
Alzheimer’s disease in the HCV-infected cohort. RESULTS: There were 830 cases of
Alzheimer’s disease reported in the HCV cohort during follow-up periods of
1,122,436.9 person-years, with incidence rates of 73.9 cases per 100,000 person-
years (95% CI, 69.1-79.2). The multivariate-adjusted HR for Alzheimer’s disease was
1.14 (95% CI, 1.02-1.26) for HCV-infected patients. The HR for HCV-infected patients
in their sixties (1.18, p  0.05) was higher than for other subgroups. There were
5,243 HCV-infected patients (4.48%) who completed antivirus therapy. The HR of
treated patients was 0.31 (95% CI 0.15-0.67) after adjusting for age, gender, income,
urbanization and the presence of other medical diseases. CONCLUSIONS: HCV
infection may increase the risk for Alzheimer’s disease. HCV antiviral therapy
could lower the risk of AD in HCV-infected patients.
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